Thrombotic complications in children with non-Hodgkin lymphoma
https://doi.org/10.17650/1818-8346-2013-8-2-41-46
Abstract
Our study was aimed at identifying of risk factors of venous thrombosis (VT) in children with non-Hodgkin lymphomas. VT episodes were registered in 13 of 174 children treated (7.5 %). Possible impact of morphological type, initial mediastinal involvement, gender, age and use of L-asparaginase as a risk factor of thrombosis development were analyzed. Using multivariate analysis primary mediastinal tumor (OR = 4.73 [CI: 1.42–17.10]) and patient age older than 13 years (OR = 4.3 [CI: 1.19–20.28) were identified as prognostic factors of thrombosis development (р < 0,05).
About the Authors
N. V. Lipay
Republican Research Center for Pediatric Oncology, Hematology and Immunology
Russian Federation
Russian Federation
A. S. Fedorova
Republican Research Center for Pediatric Oncology, Hematology and Immunology
Russian Federation
Russian Federation
V. V. Dmitriev
Republican Research Center for Pediatric Oncology, Hematology and Immunology
Russian Federation
Russian Federation
References
1. Lee A., Levine M. Venous thromboembolism and cancer: risk and outcomes. Circulation 2003;107:17–21.
2. Lip G.Y., Chin B.S., Blann A.D. Cancer and prothrombotic state. Lancet Oncol 2002;3(1):27–34.
3. Athale U.H., Chan A. Thrombosis in children with acute lymphoblastic leukemia. Part II. Pathogenesis of thrombosis in children with acute lymphoblastic leukemia: effects of the disease and therapy. Thromb Res 2003;111:199–212.
4. Garth B., Lloyd D. Thrombosis associated with L-asparaginase therapy and low fibrinogen levels in adult acute lymphoblastic leukemia. Am J Hematol 2004;77:331–5.
5. Zakarija A., Kwaan H.C. Adverse effects on hemostatic function of drugs used in hematologic malignancies. Semin Thromb Hemost 2007;33:355–64.
6. Khorana A.A., Francis C.W., Culakova E. et al. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost 2007;5(3):632–4.
7. Kwaan H.C., Vicuna B. Incidence and pathogenesis of thrombosis in hematologic malignances. Semin Thromb Hemost 2007;33(4):303–12.
8. Caruso V., Di Castelnuovo A., Meschengieser S. et al. Thrombotic complications in patients with lymphoma: a meta-analysis of 29 independent cohorts including 18 018 patients and 1149 events.Blood 2010;115:5322–8.
9. Athale U.H., Chan A.K. Thromboembolic complications in pediatric patients with hematologic malignancies. Semin Thromb Hemost 2007;33(4):416–26.
10. Athale U.H., Siciliano S., Thabane L. et al. Epidemiology and clinical risk factors predisposing to thromboembolism in children with cancer. Pediatr Blood Cancer 2008;51(6):792–7.
11. Mitchell L.G. A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-Asparaginase. Cancer 2003;97(2):508–16.
12. Mitchell L.G., Lambers M., Flege S. et al. Validation of a predictive model for identifying an increased risk for thromboembolism in children with acute lymphoblastic leukemia: results of a
13. multicentral cohort study. Blood 2010;115(24):4999–5004.
14. Swerdlow S.H., Campo E., Harris N.L. et al. WHO Classification of Tumours, Volume 2; IARC WHO Classification of Tumours, No 2. Lyon,France, IARC Press, 2008. 439 p.
15. Murphy S.B. Classification, staging and end results of treatment of childhood non- Hodgkins lymphomas: dissimilarities from lymphomas in adults. Semin Oncol 1990;7:332–8.
16. Cazals-Hatem D., Lepage E., Brice P. et al. Primary mediastinal large B-cell lymphoma: a clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA (“Groupe d'Etude des Lymphomas de l'Adulte”) study. Am J Surg Pathol 1996;20(7):877–88.
17. Lipay N.V., Dmitriev V.V., Borisenok M.B. Thrombotic complications during cancer treatment in children. Exp Oncol 2007;29(3):31–5.
18. Khorana A.A., Francis C.W., Culakova E. et al. Thromboembolism in hospitalized neutropenic cancer patients. J Clin Oncol 2006;24:484–90.
19. Athale U.H., Nagel K., Khan A.A., Chan A.K.C. Thromboembolism in children with lymphoma. Thromb Res 2008;122:459–65.
20. Blom J.W., Doggen C.J., Osanto S., Rosendaal F.R. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 2005;293(6): 715–22.
21. Pusterla S., Previtali S., Marziali S. et al. Antiphospholipid antibodies in lymphoma: prevalence and clinical significance. Hematol J 2004;5(4):341–6.
Review
For citations:
Lipay N.V., Fedorova A.S., Dmitriev V.V. Thrombotic complications in children with non-Hodgkin lymphoma. Oncohematology. 2013;8(2):41-46. (In Russ.) https://doi.org/10.17650/1818-8346-2013-8-2-41-46
Views:
9662
Email this article 